Reduced-dose Radiation Therapy to the Primary Site is Effective for High-risk Neuroblastoma: Results from a Prospective Trial

PURPOSE: For patients with high-risk neuroblastoma (HR-NB), a dose of 21 Gy to the primary tumor site after gross total resection (GTR) provides excellent local control. However, no clinical trial has specifically evaluated the optimal dose of radiation therapy (RT), and RT-related long-term toxicit...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Int J Radiat Oncol Biol Phys
Main Authors: Casey, Dana L., Kushner, Brian H., Cheung, Nai-Kong V., Modak, Shakeel, Basu, Ellen M., Roberts, Stephen S., LaQuaglia, Michael P., Wolden, Suzanne L.
Formato: Artigo
Idioma:Inglês
Publicado em: 2019
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6499671/
https://ncbi.nlm.nih.gov/pubmed/30763661
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ijrobp.2019.02.004
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados